tiprankstipranks
Advertisement

JMID - ETF AI Analysis

Compare

Top Page

JMID

Janus Henderson Mid Cap Growth Alpha ETF (JMID)

Rating:72Outperform
Price Target:
JMID, the Janus Henderson Mid Cap Growth Alpha ETF, earns a solid overall rating thanks to strong core holdings like Comfort Systems USA, Ross Stores, Dexcom, Vertiv, and Idexx Laboratories, which all show healthy financial performance, positive earnings calls, and generally supportive technical trends. The rating is held back somewhat by names like Ameriprise Financial and Cencora, where weaker revenue or margins, higher leverage, and some bearish or mixed technical signals introduce added risk. Overall, investors should be aware that many top holdings trade at relatively high valuations, which can increase sensitivity to market pullbacks.
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Comfort Systems, Vertiv Holdings, and Medpace, have shown strong year-to-date gains, helping support the fund’s overall performance.
Broad Sector Diversification
The ETF spreads its investments across many sectors, including industrials, consumer cyclical, health care, technology, and financials, which helps reduce reliance on any single industry.
Moderate Expense Ratio
The fund’s expense ratio is moderate for an actively managed mid-cap growth strategy, so fees are not excessively high relative to its category.
Negative Factors
Recent Short-Term Weakness
Despite a positive year-to-date result, the ETF has shown weak performance over the last three months, indicating recent pressure on returns.
Concentrated in U.S. Market
With almost all assets invested in U.S. companies and only a very small allocation to the UK, the fund offers limited geographic diversification.
Exposure to Lagging Holding
One of the top holdings, Expedia, has delivered weak year-to-date performance, which can drag on the fund if the stock continues to struggle.

JMID vs. SPDR S&P 500 ETF (SPY)

JMID Summary

The Janus Henderson Mid Cap Growth Alpha ETF (JMID) invests mainly in medium-sized U.S. companies that are trying to grow quickly, rather than tracking a specific index. It spreads money across many areas of the economy, including industrials, consumer companies, health care, and technology. Well-known names in the fund include Expedia and Cardinal Health. Someone might invest in JMID to seek higher growth than large, established companies while still avoiding the smallest, riskiest stocks. A key risk is that growth-focused mid-cap stocks can be more volatile and can go up and down more than the overall market.
How much will it cost me?The Janus Henderson Mid Cap Growth Alpha ETF (JMID) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, aiming to select mid-cap stocks with strong growth potential rather than tracking a broad index.
What would affect this ETF?The Janus Henderson Mid Cap Growth Alpha ETF (JMID) could benefit from economic growth and innovation in sectors like technology and consumer cyclical, as well as increased spending in industries such as healthcare and financials. However, it may face challenges from rising interest rates, which can negatively impact growth-focused companies, and economic slowdowns, which could reduce consumer spending and industrial activity. Its U.S. focus also makes it sensitive to domestic regulatory changes and geopolitical events.

JMID Top 10 Holdings

JMID leans heavily into U.S. mid-cap growth, with industrial and consumer names steering the ship. Vertiv and Comfort Systems have been rising stars, giving the fund a lift as demand for infrastructure and services stays strong. On the consumer side, Ross Stores has been quietly powering ahead, while Tapestry’s more mixed run adds some bumpiness. Health-care holdings like Dexcom are steady but no longer sprinting, and financial name Ameriprise is lagging, acting as a small drag. Overall, the fund is concentrated in cyclical growth stories rather than Big Tech giants.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Vertiv Holdings5.09%$809.95K$100.36B317.01%
77
Outperform
Howmet Aerospace4.52%$718.80K$94.63B105.92%
67
Neutral
Cencora3.47%$551.16K$62.42B16.80%
70
Neutral
Comfort Systems3.29%$523.47K$50.12B356.39%
80
Outperform
Ameriprise Financial2.85%$453.41K$39.39B1.42%
64
Neutral
Tapestry2.41%$383.89K$28.39B131.35%
69
Neutral
Idexx Laboratories2.34%$372.40K$45.77B59.21%
78
Outperform
Jabil2.29%$364.23K$28.81B126.71%
73
Outperform
Ross Stores2.20%$350.13K$69.74B70.48%
80
Outperform
Dexcom2.19%$348.85K$24.29B3.99%
79
Outperform

JMID Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
29.13
Negative
100DMA
29.27
Negative
200DMA
29.38
Negative
Market Momentum
MACD
-0.25
Negative
RSI
51.11
Neutral
STOCH
82.86
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JMID, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 28.39, equal to the 50-day MA of 29.13, and equal to the 200-day MA of 29.38, indicating a neutral trend. The MACD of -0.25 indicates Negative momentum. The RSI at 51.11 is Neutral, neither overbought nor oversold. The STOCH value of 82.86 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JMID.

JMID Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$16.42M0.30%
72
Outperform
$99.27M0.52%
73
Outperform
$86.82M0.45%
68
Neutral
$38.92M0.80%
70
Neutral
$38.41M0.55%
71
Outperform
$32.34M0.59%
64
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JMID
Janus Henderson Mid Cap Growth Alpha ETF
28.58
4.92
20.79%
AMID
Argent Mid Cap ETF
MID.ETF
American Century Mid Cap Growth Impact ETF
KMID
Virtus KAR Mid-Cap ETF
TSCM
TimesSquare Quality Mid Cap Growth ETF
MMID
MFS Active Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement